NEU1 and galactosialidosis: Thus, mutation analysis of the patient’s CTSA gene and biochemical assessment of the cathepsin A, β-galactosidase, and neuraminidase-1 activities in cultured fibroblasts should be performed to support the diagnosis of early infantile galactosialidosis.